Effects of medication reviews performed by a physician on treatment with fracture-Preventing and fall-risk-increasing drugs in older adults with hip fracture - A randomized controlled study

Journal of the American Geriatrics Society

Volumn 61, Issue 9, 2013, Pages 1464-1472

  Sjöberg, Christina ^a   Wallerstedt, Susanna M ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

fall risk; hip fracture; medication review; older people; osteoporosis

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; HYPNOTIC SEDATIVE AGENT; NEUROLEPTIC AGENT; SEDATIVE AGENT; VASODILATOR AGENT;

AGED; CONTROLLED STUDY; FALL RISK ASSESSMENT; FEMALE; FRACTURE; HIP FRACTURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; PHYSICIAN; PHYSICIAN ATTITUDE; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; REVIEW;

FALL RISK; HIP FRACTURE; MEDICATION REVIEW; OLDER PEOPLE; OSTEOPOROSIS;

ACCIDENTAL FALLS; AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; FOLLOW-UP STUDIES; HIP FRACTURES; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; PHYSICIANS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SWEDEN; TIME FACTORS;

EID: 84884291244     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12412     Document Type: Review

References (47)

1. Leipzig RM, Cumming RG, Tinetti ME,. Drugs and falls in older people: A systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc 1999; 47: 40-50.
2. Leipzig RM, Cumming RG, Tinetti ME,. Drugs and falls in older people: A systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999; 47: 30-39.
3. Huang AR, Mallet L, Rochefort CM, et al. Medication-related falls in the elderly: Causative factors and preventive strategies. Drugs Aging 2012; 29: 359-376.
4. Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009; 169: 1952-1960.
5. van der Velde N, Stricker BH, Pols HA, et al. Risk of falls after withdrawal of fall-risk-increasing drugs: A prospective cohort study. Br J Clin Pharmacol 2007; 63: 232-237.
6. Salonoja M, Salminen M, Vahlberg T, et al. Withdrawal of psychotropic drugs decreases the risk of falls requiring treatment. Arch Gerontol Geriatr 2012; 54: 160-167.
7. Panneman MJ, Lips P, Sen SS, et al. Undertreatment with anti-osteoporotic drugs after hospitalization for fracture. Osteoporos Int 2004; 15: 120-124.
8. Johnell K, Fastbom J,. Undertreatment of osteoporosis in the oldest old? A nationwide study of over 700,000 older people. Arch Osteoporos 2009; 4: 17-23.
9. Lyles KW, Colon-Emeric CS, Magaziner JS, et al. Zoledronic acid in reducing clinical fracture and mortality after hip fracture. N Engl J Med 2007; 357:nihpa40967.
10. Center JR, Bliuc D, Nguyen ND, et al. Osteoporosis medication and reduced mortality risk in elderly women and men. J Clin Endocrinol Metab 2011; 96: 1006-1014.
11. Kanis JA, Johnell O, Oden A, et al. Long-term risk of osteoporotic fracture in Malmo. Osteoporos Int 2000; 11: 669-674.
12. Sernbo I, Johnell O,. Consequences of a hip fracture: A prospective study over 1 year. Osteoporos Int 1993; 3: 148-153.
13. Kanis JA, Oden A, Johnell O, et al. The components of excess mortality after hip fracture. Bone 2003; 32: 468-473.
14. Leslie WD, LaBine L, Klassen P, et al. Closing the gap in postfracture care at the population level: A randomized controlled trial. Can Med Assoc J 2012; 184: 290-296.
15. Rozental TD, Makhni EC, Day CS, et al. Improving evaluation and treatment for osteoporosis following distal radial fractures. A prospective randomized intervention. J Bone Joint Surg Am 2008; 90: 953-961.
16. Ayoub WT, Newman ED, Blosky MA, et al. Improving detection and treatment of osteoporosis: Redesigning care using the electronic medical record and shared medical appointments. Osteoporos Int 2009; 20: 37-42.
17. Holland R, Desborough J, Goodyer L, et al. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol 2008; 65: 303-316.
18. Walsh EK, Cussen K,. "Take ten minutes": A dedicated ten minute medication review reduces polypharmacy in the elderly. Ir Med J 2010; 103: 236-238.
19. Garfinkel D, Mangin D,. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: Addressing polypharmacy. Arch Intern Med 2010; 170: 1648-1654.
20. Monteserin R, Brotons C, Moral I, et al. Effectiveness of a geriatric intervention in primary care: A randomized clinical trial. Fam Pract 2010; 27: 239-245.
21. Legrain S, Tubach F, Bonnet-Zamponi D, et al. A new multimodal geriatric discharge-planning intervention to prevent emergency visits and rehospitalizations of older adults: The optimization of medication in AGEd multicenter randomized controlled trial. J Am Geriatr Soc 2011; 59: 2017-2028.
22. Sergi G, De Rui M, Sarti S, et al. Polypharmacy in the elderly: Can comprehensive geriatric assessment reduce inappropriate medication use? Drugs Aging 2011; 28: 509-518.
23. Kanis JA,. Assessment of Osteoporosis at the Primary Health-Care Level. Sheffield, UK: World Health Organization Collaborating Centre for Metabolic Bone Diseases, 2007.
24. Ganz DA, Bao Y, Shekelle PG, et al. Will my patient fall? JAMA 2007; 297: 77-86.
25. Kallin K, Lundin-Olsson L, Jensen J, et al. Predisposing and precipitating factors for falls among older people in residential care. Public Health 2002; 116: 263-271.
26. Qaseem A, Snow V, Shekelle P, et al. Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: A clinical practice guideline from the American College of Physicians. Ann Intern Med 2008; 149: 404-415.
27. Indikatorer för god läkemedelsterapi hos äldre [Indicators for appropriate drug therapy in the elderly]. Swedish. Socialstyrelsen [The Swedish National Board on Health and Welfare]. Available at http://www. socialstyrelsen.se/publikationer2010/2010–6-29 Accessed June 12, 2012.
28. Sjoberg C, Bladh L, Klintberg L, et al. Treatment with fall-risk-increasing and fracture-preventing drugs before and after a hip fracture: An observational study. Drugs Aging 2010; 27: 653-661.
29. Haynes SR, Lawler PG,. An assessment of the consistency of ASA physical status classification allocation. Anaesthesia 1995; 50: 195-199.
30. Weber V, White A, McIlvried R,. An electronic medical record (EMR)-based intervention to reduce polypharmacy and falls in an ambulatory rural elderly population. J Gen Intern Med 2008; 23: 399-404.
31. Casteel C, Blalock SJ, Ferreri S, et al. Implementation of a community pharmacy-based falls prevention program. Am J Geriatr Pharmacother 2011; 9: 310-319 e312.
32. Johnell O, Kanis JA, Oden A, et al. Mortality after osteoporotic fractures. Osteoporos Int 2004; 15: 38-42.
33. Soderqvist A, Ekstrom W, Ponzer S, et al. Prediction of mortality in elderly patients with hip fractures: A two-year prospective study of 1,944 patients. Gerontology 2009; 55: 496-504.
34. Fletcher AE, Price GM, Ng ES, et al. Population-based multidimensional assessment of older people in UK general practice: A cluster-randomised factorial trial. Lancet 2004; 364: 1667-1677.
35. Vanden Bussche P, Desmyter F, Duchesnes C, et al. Geriatric day hospital: Opportunity or threat? A qualitative exploratory study of the referral behaviour of Belgian general practitioners BMC Health Serv Res 2010; 10: 202.
36. Midlov P, Bergkvist A, Bondesson A, et al. Medication errors when transferring elderly patients between primary health care and hospital care. Pharm World Sci 2005; 27: 116-120.
37. Farup PG, Blix I, Forre S, et al. What causes treatment failure-the patient, primary care, secondary care or inadequate interaction in the health services? BMC Health Serv Res 2011; 11: 111.
38. Cumbler E, Carter J, Kutner J,. Failure at the transition of care: Challenges in the discharge of the vulnerable elderly patient. J Hosp Med 2008; 3: 349-352.
39. Holland R, Lenaghan E, Harvey I, et al. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial BMJ 2005; 330: 293.
40. Kwint HF, Faber A, Gussekloo J, et al. Effects of medication review on drug-related problems in patients using automated drug-dispensing systems: A pragmatic randomized controlled study. Drugs Aging 2011; 28: 305-314.
41. Lisby M, Thomsen A, Nielsen LP, et al. The effect of systematic medication review in elderly patients admitted to an acute ward of internal medicine. Basic Clin Pharmacol Toxicol 2010; 106: 422-427.
42. Nkansah N, Mostovetsky O, Yu C, et al. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev 2010;(7):CD000336.
43. Wallerstedt SM, Bladh L, Ramsberg J,. A cost-effectiveness analysis of an in-hospital clinical pharmacist service. BMJ Open 2012; 2: e000329.
44. Schuling J, Gebben H, Veehof LJ, et al. Deprescribing medication in very elderly patients with multimorbidity: The view of Dutch GPs. A qualitative study. BMC Fam Pract 2012; 13: 56.
45. Loganathan M, Singh S, Franklin BD, et al. Interventions to optimise prescribing in care homes: Systematic review. Age Ageing 2011; 40: 150-162.
46. Christensen M, Lundh A,. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev 2013;(2):CD008986.
47. WHO Collaborating Centre for Drug Statistics Methodology [on-line]. Available at http://www.whocc.no Accessed June 11, 2012.